Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 351598, 7 pages
http://dx.doi.org/10.1155/2014/351598
Research Article

Vitamin B6 Supplementation Improves Oxidative Stress and Enhances Serum Paraoxonase/Arylesterase Activities in Streptozotocin-Induced Diabetic Rats

1Department of Biology, Science and Literature Faculty, Uludağ University, 16059 Bursa, Turkey
2Department of Biochemistry, Medical Faculty, Uludağ University, 16059 Bursa, Turkey

Received 20 June 2014; Revised 1 October 2014; Accepted 15 October 2014; Published 6 November 2014

Academic Editor: Daiana Avila

Copyright © 2014 Sibel Taş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. P. Wolff and R. T. Dean, “Glucose autoxidation and protein modification. The potential role of “autoxidative glycosylation” in diabetes,” Biochemical Journal, vol. 245, no. 1, pp. 243–250, 1987. View at Google Scholar · View at Scopus
  2. N. Mishra and N. Singh, “Blood viscosity, lipid profile, and lipid peroxidation in type-1 diabetic patients with good and poor glycemic control,” North American Journal of Medical Sciences, vol. 5, no. 9, pp. 562–566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Martín-Gallán, A. Carrascosa, M. Gussinyé, and C. Domínguez, “Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications,” Free Radical Biology and Medicine, vol. 34, no. 12, pp. 1563–1574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. R. Zatalia and H. Sanusi, “The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus,” Acta Medica Indonesiana, vol. 45, no. 2, pp. 141–147, 2013. View at Google Scholar · View at Scopus
  5. M. I. Mackness, B. Mackness, P. N. Durrington, P. W. Connelly, and R. A. Hegele, “Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins,” Current Opinion in Lipidology, vol. 7, no. 2, pp. 69–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Mackness, R. Hunt, P. N. Durrington, and M. I. Mackness, “Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 7, pp. 1233–1238, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Mackness and B. Mackness, “Targeting paraoxonase-1 in atherosclerosis,” Expert Opinion on Therapeutic Targets, vol. 17, no. 7, pp. 829–837, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. K. Spady, “Reverse cholesterol transport and atherosclerosis regression,” Circulation, vol. 100, no. 6, pp. 576–578, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. B. N. Patel, M. I. Mackness, D. W. Harty, S. Arrol, R. P. Boot-Hanford, and P. N. Durrington, “Serum esterase activities and hyperlipidaemia in the streptozotocin—diabetic rat,” Biochimica et Biophysica Acta: General Subjects, vol. 1035, no. 1, pp. 113–116, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Aviram, S. Billecke, R. Sorenson et al., “Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 10, pp. 1617–1624, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Y. Gbandjaba, N. Ghalim, M. Hassar et al., “Paraoxonase activity in healthy, diabetic, and hemodialysis patients,” Clinical Biochemistry, vol. 45, no. 6, pp. 470–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. I. Mackness, D. Harty, D. Bhatnagar et al., “Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus,” Atherosclerosis, vol. 86, no. 2-3, pp. 193–199, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Boemi, I. Leviev, C. Sirolla, C. Pieri, M. Marra, and R. W. James, “Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation,” Atherosclerosis, vol. 155, no. 1, pp. 229–235, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bub, S. W. Barth, B. Watzl, K. Briviba, and G. Rechkemmer, “Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice,” British Journal of Nutrition, vol. 93, no. 3, pp. 291–297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Calla and S. M. Lynch, “Vitamin C preserves the cardio-protective paraoxonase activity of high-density lipoprotein during oxidant stress,” Archives of Biochemistry and Biophysics, vol. 452, no. 2, pp. 129–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Aviram, M. Rosenblat, S. Billecke et al., “Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants,” Free Radical Biology and Medicine, vol. 26, no. 7-8, pp. 892–904, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. J. F. Angel, “Gluconeogenesis in meal-fed, vitamin B-6-deficient rats,” Journal of Nutrition, vol. 110, no. 2, pp. 262–269, 1980. View at Google Scholar · View at Scopus
  18. J. M. Matxain, M. Ristilä, Å. Strid, and L. A. Eriksson, “Theoretical study of the antioxidant properties of pyridoxine,” The Journal of Physical Chemistry A, vol. 110, no. 48, pp. 13068–13072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Higashi-Okai, H. Nagino, K. Yamada, and Y. Okai, “Antioxidant and prooxidant activities of B group vitamins in lipid peroxidation,” Journal of UOEH, vol. 28, no. 4, pp. 359–368, 2006. View at Google Scholar · View at Scopus
  20. L. Cabrini, R. Bergami, D. Fiorentini, M. Marchetti, L. Landi, and B. Tolomelli, “Vitamin B6 deficiency affects antioxidant defences in rat liver and heart,” Biochemistry and Molecular Biology International, vol. 46, no. 4, pp. 689–697, 1998. View at Google Scholar · View at Scopus
  21. B. K. Ohta and C. S. Foote, “Characterization of endoperoxide and hydroperoxide intermediates in the reaction of pyridoxine with singlet oxygen,” Journal of the American Chemical Society, vol. 124, no. 41, pp. 12064–12065, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Matxain, D. Padro, M. Ristilä, A. Strid, and L. A. Eriksson, “Evidence of high ·OH radical quenching efficiency by vitamin B 6,” Journal of Physical Chemistry B, vol. 113, no. 29, pp. 9629–9632, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Keles, B. Al, K. Gumustekin et al., “Antioxidative status and lipid peroxidation in kidney tissue of rats fed with vitamin B6-deficient diet,” Renal Failure, vol. 32, no. 5, pp. 618–622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Leklem and C. B. Hollenbeck, “Acute ingestion of glucose decreases plasma pyridoxal 5′-phosphate and total vitamin B-6 concentration,” The American Journal of Clinical Nutrition, vol. 51, no. 5, pp. 832–838, 1990. View at Google Scholar · View at Scopus
  25. A. M. Huber, S. N. Huber, and D. B. Hegsted, “Carbohydrate and fat metabolism and response to insulin in vitamin B6 deficient rats,” Journal of Nutrition, vol. 82, pp. 371–378, 1964. View at Google Scholar · View at Scopus
  26. B. G. Kelso, J. B. Brower, J. H. Targovnik, and M. R. Caplan, “Pyridoxine restores endothelial cell function in high glucose,” Metabolic Syndrome and Related Disorders, vol. 9, no. 1, pp. 63–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Okada, M. Shibuya, E. Yamamoto, and Y. Murakami, “Effect of diabetes on vitamin B6 requirement in experimental animals,” Diabetes, Obesity and Metabolism, vol. 1, no. 4, pp. 221–225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. H. W. Eckerson, C. M. Wyte, and B. N. La Du, “The human serum paraoxonase/arylesterase polymorphism,” The American Journal of Human Genetics, vol. 35, no. 6, pp. 1126–1138, 1983. View at Google Scholar · View at Scopus
  29. L. Haagen and A. Brock, “A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate,” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 30, no. 7, pp. 391–395, 1992. View at Google Scholar · View at Scopus
  30. V. Fairbanks and G. G. Klee, “Biochemical aspects of haematology,” in Tietz Textbook of Clinical Chemistry, C. A. Burtis and E. R. Ashwood, Eds., pp. 2020–2021, WB Saunders, Philadelphia, Pa, USA, 1994. View at Google Scholar
  31. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  32. I. S. Young and E. R. Trimble, “Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection,” Annals of Clinical Biochemistry, vol. 28, no. 5, pp. 504–508, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Nielsen, B. B. Mikkelsen, J. B. Nielsen, H. R. Andersen, and P. Grandjean, “Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors,” Clinical Chemistry, vol. 43, no. 7, pp. 1209–1214, 1997. View at Google Scholar · View at Scopus
  34. G. L. King and M. R. Loeken, “Hyperglycemia-induced oxidative stress in diabetic complications,” Histochemistry and Cell Biology, vol. 122, no. 4, pp. 333–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Z. Kedziora-Kornatowska, M. Luciak, J. Błaszczyk, and W. Pawlak, “Effect of aminoguanidine on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes,” Clinical Chemistry and Laboratory Medicine, vol. 36, no. 10, pp. 771–775, 1998. View at Google Scholar · View at Scopus
  36. Y. Aliciguzel, I. Ozen, M. Aslan, and U. Karayalcin, “Activities of xanthine oxidoreductose and antioxidant enzymes in different tissues of diabetic rats,” The Journal of Laboratory and Clinical Medicine, vol. 142, no. 3, pp. 172–177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. W.-C. Huang, S.-W. Juang, I.-M. Liu, T.-C. Chi, and J.-T. Cheng, “Changes of superoxide dismutase gene expression and activity in the brain of streptozotocin-induced diabetic rats,” Neuroscience Letters, vol. 275, no. 1, pp. 25–28, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. S.-I. Yamagishi, D. Edelstein, X.-L. Du, and M. Brownlee, “Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction,” Diabetes, vol. 50, no. 6, pp. 1491–1494, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Tas, S. Celikler, S. Ziyanok-Ayvalik, E. Sarandol, and M. Dirican, “Ulva rigida improves carbohydrate metabolism, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats,” Cell Biochemistry and Function, vol. 29, no. 2, pp. 108–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Celikler, S. Tas, O. Vatan, S. Ziyanok-Ayvalik, G. Yildiz, and R. Bilaloglu, “Anti-hyperglycemic and antigenotoxic potential of Ulva rigida ethanolic extract in the experimental diabetes mellitus,” Food and Chemical Toxicology, vol. 47, no. 8, pp. 1837–1840, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Tas, E. Sarandol, S. Z. Ayvalik, Z. Serdar, and M. Dirican, “Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems,” Archives of Medical Research, vol. 38, no. 3, pp. 276–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Aviram and J. Vaya, “Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion,” Current Opinion in Lipidology, vol. 24, no. 4, pp. 339–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Wegner, M. Pioruńska-Stolzmann, A. Araszkiewicz, D. Zozulińska-Ziołkiewicz, and B. Wierusz-Wysocka, “Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes,” Polskie Archiwum Medycyny Wewnetrznej, vol. 121, no. 12, pp. 448–455, 2011. View at Google Scholar · View at Scopus
  44. S. Tas, E. Sarandol, S. Ziyanok-Ayvalik, N. Ocak, Z. Serdar, and M. Dirican, “Vanadyl sulfate treatment improves oxidative stress and increases serum paraoxonase activity in streptozotocin-induced diabetic rats,” Nutrition Research, vol. 26, no. 12, pp. 670–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Aviram, M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. la Du, “Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase,” The Journal of Clinical Investigation, vol. 101, no. 8, pp. 1581–1590, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Amine, A. Atouk, S. Moussamih, R. Saile, A. Mikou, and A. Kettani, “Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients,” Annales de Biologie Clinique, vol. 69, no. 6, pp. 671–677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Tas, E. Sarandol, S. Ziyanok, K. Aslan, and M. Dirican, “Effects of green tea on serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats,” Nutrition Research, vol. 25, no. 12, pp. 1061–1074, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. K. S. Rogers and C. Mohan, “Vitamin B6 metabolism and diabetes,” Biochemical medicine and metabolic biology, vol. 52, no. 1, pp. 10–17, 1994. View at Publisher · View at Google Scholar · View at Scopus
  49. P. G. Massé, J. Boudreau, C. C. Tranchant, R. Ouellette, and K. L. Ericson, “Type 1 diabetes impairs vitamin B6 metabolism at an early stage of women's adulthood,” Applied Physiology, Nutrition and Metabolism, vol. 37, no. 1, pp. 167–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Rubí, “Pyridoxal 5′-phosphate (PLP) deficiency might contribute to the onset of type I diabetes,” Medical Hypotheses, vol. 78, no. 1, pp. 179–182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Makris and S. N. Gershoff, “Insulin sensitivity in vitamin B6 deficient rats. Effects of acute and chronic growth hormone treatment,” Nutrition and Metabolism, vol. 16, no. 6, pp. 337–351, 1974. View at Publisher · View at Google Scholar · View at Scopus
  52. K. E. MacKenzie, E. J. Wiltshire, R. Gent, C. Hirte, L. Piotto, and J. J. Couper, “Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus,” Pediatrics, vol. 118, no. 1, pp. 242–253, 2006. View at Publisher · View at Google Scholar · View at Scopus